110 related articles for article (PubMed ID: 9433779)
1. Synthesis and radiolabeling of (S)-4-amino-5-iodo-2-methoxy-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamide, the active enantiomer of [125I]iodozacopride, and re-evaluation of its 5-HT3 receptor affinity.
Hewlett WA; de Paulis T; Mason NS; Schmidt DE; Trivedi BL; Zhang ZJ; Ebert MH
Chem Pharm Bull (Tokyo); 1997 Dec; 45(12):2079-84. PubMed ID: 9433779
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of [125I]-(S)-iodozacopride, a high affinity radioligand for 5HT3 receptors.
Gehlert DR; Schober DA; Gackenheimer SL; Mais DE; Ladouceur G; Robertson DW
Neurochem Int; 1993 Oct; 23(4):373-83. PubMed ID: 8220179
[TBL] [Abstract][Full Text] [Related]
3. Characterization of (S)-des-4-amino-3-[125I]iodozacopride ([125I]DAIZAC), a selective high-affinity radioligand for 5-hydroxytryptamine3 receptors.
Hewlett WA; Trivedi BL; Zhang ZJ; de Paulis T; Schmidt DE; Lovinger DM; Ansari MS; Ebert MH
J Pharmacol Exp Ther; 1999 Jan; 288(1):221-31. PubMed ID: 9862774
[TBL] [Abstract][Full Text] [Related]
4. Distribution of S(-)-zacopride-insensitive [125I]R(+)-zacopride binding sites in the rat brain and peripheral tissues.
Ge J; Barnes JM; Towers P; Barnes NM
Eur J Pharmacol; 1997 Aug; 332(3):307-12. PubMed ID: 9300265
[TBL] [Abstract][Full Text] [Related]
5. Characterization of desamino-5-[125I]iodo-3-methoxy-zacopride ([125I]MIZAC) binding to 5-HT3 receptors in the rat brain.
Hewlett WA; Fridman S; Trivedi BL; Schmidt DE; de Paulis T; Ebert MH
Prog Neuropsychopharmacol Biol Psychiatry; 1998 Feb; 22(2):397-410. PubMed ID: 9608609
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of the non-5-HT3 high-affinity 'R' binding site for (R)-zacopride in brain and other tissues.
Kidd FJ; Levy JC; Nielsen M; Hamon M; Gozlan H
Eur J Pharmacol; 1993 Sep; 247(1):45-56. PubMed ID: 8258360
[TBL] [Abstract][Full Text] [Related]
7. Purification of 5-hydroxytryptamine3 receptors from porcine brain.
Fletcher S; Barnes NM
Br J Pharmacol; 1997 Oct; 122(4):655-62. PubMed ID: 9375961
[TBL] [Abstract][Full Text] [Related]
8. [(125I)iodo-zacopride: new ligand for the study by autoradiography of central 5-HT3 receptors].
Koscielniak T; Ponchant M; Laporte AM; Guminski Y; Verge D; Hamon M; Gozlan H
C R Acad Sci III; 1990; 311(6):231-7. PubMed ID: 2121314
[TBL] [Abstract][Full Text] [Related]
9. Quantitative autoradiographic mapping of 5-HT3 receptors in the rat CNS using [125I]iodo-zacopride and [3H]zacopride as radioligands.
Laporte AM; Koscielniak T; Ponchant M; Vergé D; Hamon M; Gozlan H
Synapse; 1992 Apr; 10(4):271-81. PubMed ID: 1585260
[TBL] [Abstract][Full Text] [Related]
10. [125I]S(-)-zacopride labels a novel 5-hydroxytryptamine sensitive recognition site in rat duodenum and ileum.
Ge J; Towers P; Patel AC; Barnes NM
Eur J Pharmacol; 1996 Apr; 300(1-2):113-7. PubMed ID: 8741175
[TBL] [Abstract][Full Text] [Related]
11. Differential distribution of 5-hydroxytryptamine3 receptor in the colon between human and guinea pig.
Sakurai-Yamashita Y; Yamashita K; Kaibara M; Enjoji A; Kanematsu T; Taniyama K
Chin J Physiol; 1999 Sep; 42(3):195-8. PubMed ID: 10707894
[TBL] [Abstract][Full Text] [Related]
12. Autoradiographic distribution of [3H]-(S)-zacopride-labelled 5-HT3 receptors in human brain.
Parker RM; Barnes JM; Ge J; Barber PC; Barnes NM
J Neurol Sci; 1996 Dec; 144(1-2):119-27. PubMed ID: 8994113
[TBL] [Abstract][Full Text] [Related]
13. Autoradiographic localization of the [3H]-(S)-zacopride labelled 5-HT3 receptor in porcine brain.
Fletcher S; Barnes NM
Neurosci Lett; 1999 Jul; 269(2):91-4. PubMed ID: 10430512
[TBL] [Abstract][Full Text] [Related]
14. [3H]zacopride: ligand for the identification of 5-HT3 recognition sites.
Barnes NM; Costall B; Naylor RJ
J Pharm Pharmacol; 1988 Aug; 40(8):548-51. PubMed ID: 2907008
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and 5-HT-3 receptor binding of 2- and 3-(halo)alkoxyl substituted (S)-N-(1-azabicyclo[2.2.2]oct-3-yl)-5-chlorobenzamides as potential radioligands.
Hewlett WA; Schmidt DE; Mason NS; Trivedi BL; Ebert MH; de Paulis T
Nucl Med Biol; 1998 Feb; 25(2):141-53. PubMed ID: 9468029
[TBL] [Abstract][Full Text] [Related]
16. Physicochemical properties of serotonin 5-HT3 binding sites solubilized from membranes of NG 108-15 neuroblastoma-glioma cells.
Miquel MC; Emerit MB; Bolaños FJ; Schechter LE; Gozlan H; Hamon M
J Neurochem; 1990 Nov; 55(5):1526-36. PubMed ID: 2213008
[TBL] [Abstract][Full Text] [Related]
17. Characterisation and autoradiographic localisation of 5-HT3 receptor recognition sites identified with [3H]-(S)-zacopride in the forebrain of the rat.
Barnes JM; Barnes NM; Champaneria S; Costall B; Naylor RJ
Neuropharmacology; 1990 Nov; 29(11):1037-45. PubMed ID: 2087255
[TBL] [Abstract][Full Text] [Related]
18. Antagonism of [3H]zacopride binding to 5-HT3 recognition sites by its (R) and (S) enantiomers.
Pinkus LM; Sarbin NS; Gordon JC; Munson HR
Eur J Pharmacol; 1990 Apr; 179(1-2):231-5. PubMed ID: 2364986
[TBL] [Abstract][Full Text] [Related]
19. Differential binding characteristics of agonists at 5-HT3 receptor recognition sites in NG108-15 neuroblastoma-glioma cells labelled by [3H]-(S)-zacopride and [3H]granisetron.
Barnes JM; Barnes NM
Biochem Pharmacol; 1993 May; 45(10):2155-8. PubMed ID: 8390263
[TBL] [Abstract][Full Text] [Related]
20. Anxiolytic-like effects of DAIZAC, a selective high-affinity 5-HT(3) receptor antagonist, in the mouse elevated plus-maze.
Zhang ZJ; Schmidt DE; de Paulis T; Trivedi BL; Onaivi ES; Ebert MH; Hewlett WA
Pharmacol Biochem Behav; 2001; 69(3-4):571-8. PubMed ID: 11509218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
